Simulations Plus Inc
SLP19.330USD
-0.010-0.05%
Cierre 12/23, 16:00（ET）Cotizaciones retrasadas 15 min
389.26MCap. mercado
PérdidaP/E TTM
Más Datos de Simulations Plus Inc Compañía
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Información de Simulations Plus Inc
Símbolo de cotizaciónSLP
Nombre de la empresaSimulations Plus Inc
Fecha de salida a bolsaJun 18, 1997
Director ejecutivoO'Connor (Shawn M)
Número de empleados212
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 18
Dirección800 Park Offices Drive, Suite 401
CiudadRESEARCH TRIANGLE PARK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal27709
Teléfono16617237723
Sitio Webhttps://www.simulations-plus.com/
Símbolo de cotizaciónSLP
Fecha de salida a bolsaJun 18, 1997
Director ejecutivoO'Connor (Shawn M)
Ejecutivos de Simulations Plus Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.29M
+0.05%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
68.87K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
13.28K
+15.39%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
10.70K
+19.84%
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Shawn M. O'Connor
Mr. Shawn M. O'Connor
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Steven Chang
Mr. Steven Chang
Global Head - Strategic Alliances
Global Head - Strategic Alliances
--
--
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.29M
+0.05%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
68.87K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
13.28K
+15.39%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
10.70K
+19.84%
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Software licenses
12.62M
61.95%
Consulting services
7.75M
38.05%
Por regiónUSD
Nombre
Ganancia
Proporción
Americas
14.54M
71.42%
Europe
3.70M
18.16%
Asia
2.12M
10.42%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Software licenses
12.62M
61.95%
Consulting services
7.75M
38.05%
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Woltosz (Walter S)
16.28%
BlackRock Institutional Trust Company, N.A.
5.29%
The Vanguard Group, Inc.
4.84%
Morgan Stanley & Co. LLC
4.13%
First Light Asset Management, LLC
3.81%
Otro
65.66%
Accionistas
Accionistas
Proporción
Woltosz (Walter S)
16.28%
BlackRock Institutional Trust Company, N.A.
5.29%
The Vanguard Group, Inc.
4.84%
Morgan Stanley & Co. LLC
4.13%
First Light Asset Management, LLC
3.81%
Otro
65.66%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
36.85%
Investment Advisor/Hedge Fund
22.13%
Individual Investor
17.30%
Hedge Fund
10.57%
Research Firm
8.86%
Pension Fund
0.49%
Bank and Trust
0.35%
Venture Capital
0.11%
Insurance Company
0.03%
Otro
3.32%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
399
15.45M
76.77%
-3.13M
2025Q2
397
20.10M
99.87%
-2.39M
2025Q1
405
20.80M
103.44%
-1.07M
2024Q4
395
19.75M
98.32%
-353.54K
2024Q3
400
19.32M
96.55%
-155.06K
2024Q2
401
20.11M
100.50%
-787.76K
2024Q1
398
20.05M
100.34%
-310.16K
2023Q4
390
19.56M
97.97%
-570.84K
2023Q3
390
19.23M
96.46%
-1.16M
2023Q2
406
19.53M
98.02%
-1.10M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Woltosz (Walter S)
3.31M
16.43%
+2.07K
+0.06%
Aug 01, 2025
BlackRock Institutional Trust Company, N.A.
2.25M
11.18%
-38.54K
-1.68%
Jun 30, 2025
The Vanguard Group, Inc.
1.17M
5.82%
+76.28K
+6.96%
Jun 30, 2025
First Light Asset Management, LLC
357.16K
1.77%
+357.16K
--
Jun 30, 2025
Rockefeller Capital Management
379.16K
1.88%
+328.27K
+645.04%
Jun 30, 2025
Columbia Threadneedle Investments (UK)
601.59K
2.99%
+178.79K
+42.29%
Jun 30, 2025
Tributary Capital Management, LLC
361.28K
1.79%
-28.63K
-7.34%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
485.40K
2.41%
+9.87K
+2.08%
Jun 30, 2025
State Street Investment Management (US)
673.69K
3.35%
-32.82K
-4.65%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
State Street SPDR FactSet Innovative Technolgy ETF
0.58%
Global X HealthTech ETF
0.31%
First Trust Active Factor Small Cap ETF
0.28%
First Trust Multi-Manager Small Cap Opportunities ETF
0.21%
Franklin Exponential Data ETF
0.12%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.09%
Principal U.S. Small-Cap ETF
0.07%
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Growth ETF
0.02%
Proshares Ultra Russell 2000
0.01%
Ver más
State Street SPDR FactSet Innovative Technolgy ETF
Proporción0.58%
Global X HealthTech ETF
Proporción0.31%
First Trust Active Factor Small Cap ETF
Proporción0.28%
First Trust Multi-Manager Small Cap Opportunities ETF
Proporción0.21%
Franklin Exponential Data ETF
Proporción0.12%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporción0.09%
Principal U.S. Small-Cap ETF
Proporción0.07%
iShares Micro-Cap ETF
Proporción0.06%
iShares Russell 2000 Growth ETF
Proporción0.02%
Proshares Ultra Russell 2000
Proporción0.01%
Dividendos
Un total de
19.26M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jul 02, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 05, 2024 going ex on Jul 29, 2024
Jul 29, 2024
Aug 05, 2024
Jul 29, 2024
Apr 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 06, 2024 going ex on Apr 26, 2024
Apr 29, 2024
May 06, 2024
Apr 26, 2024
Jan 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 05, 2024 going ex on Jan 26, 2024
Jan 29, 2024
Feb 05, 2024
Jan 26, 2024
Oct 25, 2023
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 06, 2023 going ex on Oct 27, 2023
Oct 30, 2023
Nov 06, 2023
Oct 27, 2023
Jul 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 07, 2023 going ex on Jul 28, 2023
Jul 31, 2023
Aug 07, 2023
Jul 28, 2023
Apr 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 01, 2023 going ex on Apr 21, 2023
Apr 24, 2023
May 01, 2023
Apr 21, 2023
Jan 05, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 06, 2023 going ex on Jan 27, 2023
Jan 30, 2023
Feb 06, 2023
Jan 27, 2023
Oct 20, 2022
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 07, 2022 going ex on Oct 28, 2022
Oct 31, 2022
Nov 07, 2022
Oct 28, 2022
Jul 07, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 01, 2022 going ex on Jul 22, 2022
Jul 25, 2022
Aug 01, 2022
Jul 22, 2022
Apr 06, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 02, 2022 going ex on Apr 22, 2022
Apr 25, 2022
May 02, 2022
Apr 22, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Simulations Plus Inc?
Los cinco principales accionistas de Simulations Plus Inc son:
Woltosz (Walter S) posee 3.31M acciones, lo que representa el 16.43% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 2.25M acciones, lo que representa el 11.18% del total de acciones.
The Vanguard Group, Inc. posee 1.17M acciones, lo que representa el 5.82% del total de acciones.
First Light Asset Management, LLC posee 357.16K acciones, lo que representa el 1.77% del total de acciones.
Rockefeller Capital Management posee 379.16K acciones, lo que representa el 1.88% del total de acciones.
Woltosz (Walter S) posee 3.31M acciones, lo que representa el 16.43% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 2.25M acciones, lo que representa el 11.18% del total de acciones.
The Vanguard Group, Inc. posee 1.17M acciones, lo que representa el 5.82% del total de acciones.
First Light Asset Management, LLC posee 357.16K acciones, lo que representa el 1.77% del total de acciones.
Rockefeller Capital Management posee 379.16K acciones, lo que representa el 1.88% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Simulations Plus Inc?
Los tres principales tipos de accionista de Simulations Plus Inc son:
Woltosz (Walter S)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Woltosz (Walter S)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
¿Cuántas instituciones poseen acciones de Simulations Plus Inc (SLP)?
A fecha de 2025Q3, 399 instituciones poseen acciones de Simulations Plus Inc, con un valor de mercado combinado de aproximadamente 15.45M, lo que representa el 76.77% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -23.09%.
¿Cuál es la mayor fuente de ganancias de Simulations Plus Inc?
El FY2025Q3, el segmento empresarial Software licenses generó la ganancia más alta para Simulations Plus Inc, ascendiendo a 12.62M y representando el 61.95% de la ganancia total.
